Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2007-06-30
2007-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Ethyl chloride spray, plastic arm gripper, vibrating instrument, hypnotic suggestions
Topical anesthetic and hypnotic distraction
Ethyl chloride spray, plastic arm gripper, vibrating instrument, hypnotic suggestions.
2
Office routine
Office routine
Standard vaccine administration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Topical anesthetic and hypnotic distraction
Ethyl chloride spray, plastic arm gripper, vibrating instrument, hypnotic suggestions.
Office routine
Standard vaccine administration
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Significant concurrent illness
* Prior invasive procedures, excluding neonatal circumcision
4 Years
6 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Berberich, F. Ralph, M.D.
INDIV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
F. Ralph Berberich, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
f. Ralph berberich, MD
Role: PRINCIPAL_INVESTIGATOR
Pediatric Medial Group
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pediatric Medical Group
Berkeley, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Berberich
Identifier Type: -
Identifier Source: org_study_id